| ASSET | YEAR | % RETURN | 
|---|---|---|
| GT Biopharma (GTBP)    | 2014    | -100%    | 
| Castellum (CTM)    | 2014    | -99.67%    | 
| Metalla Royalty & Streaming (MTA)    | 2014    | -96.1%    | 
| BTCS (BTCS)    | 2014    | -94.67%    | 
| Centrus Energy (LEU)    | 2014    | -94.31%    | 
| DiaMedica Therapeutics (DMAC)    | 2014    | -93.85%    | 
| Ambow Education (AMBO)    | 2014    | -92%    | 
| TechPrecision Corporation Common stock (TPCS)    | 2014    | -89.83%    | 
| Dominari (DOMH)    | 2014    | -88.34%    | 
| Atlas Lithium Corporation Common Stock (ATLX)    | 2014    | -87.27%    | 
| Wintergreen Acquisition Corp Ordinary Shares (WTG)    | 2014    | -85.14%    | 
| Nixxy (NIXX)    | 2014    | -85%    | 
| MDxHealth SA ADR (MDXH)    | 2014    | -85%    | 
| AmpliTech (AMPG)    | 2014    | -84.65%    | 
| Marker Therapeutics (MRKR)    | 2014    | -84.62%    | 
| Quantum Computing  (QUBT)    | 2014    | -83.33%    | 
| TROOPS (TROO)    | 2014    | -81.98%    | 
| STRATA Skin Sciences (SSKN)    | 2014    | -81.79%    | 
| XWELL (XWEL)    | 2014    | -81.73%    | 
| Plus Therapeutics (PSTV)    | 2014    | -80.78%    | 
| Westport Fuel Systems (WPRT)    | 2014    | -80.75%    | 
| BioLife Solutions (BLFS)    | 2014    | -80.48%    | 
| Civeo (CVEO)    | 2014    | -80.34%    | 
| Arcturus Therapeutics (ARCT)    | 2014    | -79.87%    | 
| Zivo Bioscience (ZIVO)    | 2014    | -79.74%    |